| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2002;39:1007.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Department of Human Genetics, University of Utah Health Sciences Center (P.L., A.R., B.G., E.H., T.C., J.T., S.X., T.I., J-M.L.), Salt Lake City; University Claude Bernard Lyon I (P.L.), Lyon, France; Howard Hughes Medical Institute (E.H., T.C., G.P., J-M.L.), Department of Obstetrics and Gynecology (T.H., K.W.), and Department of Pathology (D.A.T.) University of Utah, Salt Lake City; and US Department of Veterans Affairs (D.A.T.), Salt Lake City, Utah.
Correspondence to Jean-Marc Lalouel, MD, DSc, Eccles Institute of Human Genetics, Eccles Building, sixth floor, University of Utah Health Sciences Center, Salt Lake City, Utah. E-mail jml{at}howard.genetics.utah.edu
| Abstract |
|---|
|
|
|---|
Key Words: angiotensinogen renin sodium mouse genetics urine
| Introduction |
|---|
|
|
|---|
The impact of dietary sodium on the expression of renin and tubular AGT and the significance of their urinary excretion as indicators of the activity of this tissue system were tested in the mouse. Two strains were investigated, C57BL/6 and CD1. The C57BL/6 inbred differs from other inbred lines in its response to dietary sodium17; its sodium sensitivity has been demonstrated18,19 and exploited in an attempt to map genetic determinants of the arterial pressure response to dietary sodium.19 We have verified this sodium sensitivity under our experimental conditions. The outbred CD1 was selected as reference, as we have found that it was sodium resistant under such protocols (P. Lantelme, E. Hillas, A. Rohrwasser, J.-M. Lalouel, unpublished, 2001). We find that in both strains, the variation in urinary AGT and renin induced by dietary sodium did not parallel that observed in the general circulation. Furthermore, C57/BL6 animals exhibited significantly higher urinary AGT excretion than did CD1 animals under both high and low sodium intake.
| Methods |
|---|
|
|
|---|
For immunohistochemical studies, 9 C57BL/6 male mice were maintained under high sodium (3.15%) for 10 days, followed by a week of low sodium (0.03%, Purina). Three animals were euthanized at each of 3 time points: the end of the high-sodium period, after the first day of the low-sodium regimen, and on the last day of the study. Kidneys were removed, hemidissected, and either snap-frozen or fixed in 10% formalin (Fisher).
Assays of Angiotensinogen
Total AGT (t-AGT) in plasma or urine was measured by ELISA (A. Rohrwasser, P. Lantelme, T. Cheng, J. Wu, J.-M. Lalouel, unpublished, 2000). Microtiter plates were coated with purified recombinant AGT. Samples or standards were added and incubated with polyclonal antimouse AGT antibody.1 Bound antibody was detected after reaction of horseradish peroxidase conjugated swine antirabbit IgG with 3-amino-9-ethylcarbazole substrate (Sigma). The assay range was 5 µg to 10 ng. The assay was specific, with no cross-reactivity to other proteins.
Uncleaved AGT (u-AGT) was measured in urine as the release of Ang I after complete digestion by highly purified renin.20 Urine samples (500 µL) were subjected to spin dialysis in a Microcon 30 (Millipore Co), diluted with 500 µL of a 10-4 M Tris-EDTA solution, and reconcentrated. Sample aliquots (5 µL) were incubated for 2 hours at 37°C with purified mouse renin (2.5 nmol/L),1 and released Ang I was measured in duplicate by radioimmunoassay (NEN-DuPont).
Measurement of Active Renin Concentration
Renin activity was measured as the amount of Ang I generated after incubation with excess AGT. Two microliters of plasma were incubated for 20 minutes at 37°C with excess porcine AGT (4 µmol/L, Sigma) in a 10-µL reaction containing sodium-acetate (50 mmol/L pH 6.5), AEBSF (2.5 mmol/L), 8-hydroxyquinoline (1 mmol/L), and EDTA (5 mmol/L). The reaction was linear for at least 30 minutes in plasma using test samples from animals under high- or low-sodium diet. The reaction was stopped by boiling, and Ang I was measured by using an indirect radioimmunoassay (NEN-DuPont). Plasma renin concentration (PRC) was expressed as Ang I generated per hour per µL of plasma.
In contrast with plasma, Ang I release in urine was rapid initially (within seconds), with no further Ang I generation. This Ang I release is of renin origin because (1) basal Ang I, in the absence of substrate addition, was undetectable or very low; (2) Ang I release varied in direct proportion with the amount of sample used; (3) it increased in direct proportion to the amount of purified recombinant renin added to a urine sample; and (4) it was prevented in a dose-dependent manner by the renin inhibitor (H-77, Sigma). Consequently, active renin concentration was measured as the amount of Ang I released during a 15-minute incubation at 37°C. The dependence of the assay on physiological variation in pH, sodium, urea, protein, and des-Ang IAGT was examined. Because sodium proved significant, the reaction buffer was adjusted to 500 mmol/L sodium chloride.
Other Measurements
Urinary aldosterone was determined by radioimmunoassay (Coat-A-Count, Diagnostic Products). Urinary sodium was measured by atomic absorption (Perkin-Elmer, model 2380). Samples obtained from the high-sodium period were diluted 1:5000 in deionized water, whereas samples from the low-sodium period were diluted 1:250. All dilutions were performed in duplicate, and each sodium measurement consisted of the average of 3 consecutive readings. Creatinine was measured in duplicate using Jaffés reaction (Sigma). Assays were performed on undiluted plasma and 1:10 diluted urine. Protein concentrations were measured using the Micro bicinchoninic assay (BCA) method (Pierce).
Immunohistochemistry
Tissue slides, immunostaining of AGT and renin, and quantitation of CNT renin were performed as described.1 Angiotensinogen in the PT was expressed on a 0 to 3 scale, with 0 for no staining, 1 for staining of <20% of only the cortical PTs, 2 for staining of 50% of all PTs and 80% of the cortical PTs, and 3 for strong and intense staining of >50% of all PTs. PTs were identified based on PAS counterstaining of brush borders. Scoring was performed by 2 investigators blinded to the experimental conditions and averaged.
Quantitative Analysis of mRNA
Total RNA was extracted from frozen tissues using Trizol reagent (Invitrogen). cDNA was prepared using reverse transcriptase (AMV reverse transcriptase, Promega) and the manufacturers standard protocol. Quantitative real-time polymerase chain reaction (PCR) analysis was performed by monitoring the fluorescence of SYBR Green (Molecular Probes) with the ABI PRISM 7700 detection system (Perkin Elmer Applied Biosystems). Oligonucleotide primers were designed to span at least 1 intron and to minimize primer-dimer formation. Samples were electrophoresed to verify specific amplification and the absence of primer-dimer formation. All PCR reactions were performed in triplicate with primers (1) specific for the corresponding mouse genes and (2) spanning at least 1 intron: 5'-GTG ACA GGG TGG AAG ATG AAC T-3' (mAGT Ex2), 5'-GGA GAT CAT GGG CAC AGA CA-3' (mAGT Ex3), and 5'-TGG GAA GCT TGT CAT CAA CG-3', 5'-ATG CAG GGA TGA TGT TCT GG-3' (mGAPDH). Amplification was performed during 40 cycles of 94°C for 30 seconds, 60°C for 30 seconds, and 68°C for 60 second. Water and genomic DNA served as negative controls. Cloned mouse cDNAs for AGT and GAPDH were used to generate standard curves. AGT concentration was expressed relative to GAPDH.
Statistical Analyses
Urinary parameters were expressed relative to creatinine to guard against incomplete urine recovery. Individual values are summarized as mean±SEM. All measurements were in the range of reference values21 or previously published observations.17,22 To examine the effects of the 2 factors, dietary sodium and genetic background, mean values were calculated for each animal over each period of sodium regimen and were subjected to 2-way ANOVA. Whenever significant heterogeneity of residual variance was indicated by Levenes test, analysis was repeated after logarithmic transformation.
| Results |
|---|
|
|
|---|
|
Metabolic and Renal Function Parameters
Mean body weight was different between strains (Table, P<0.00001). A trend toward lower food intake in C57BL/6 compared with CD1 (P=0.09) reflected this size difference. Although food consumption varied significantly with sodium regimen (P<0.0001), body weight was not significantly affected (P=0.4). As expected, diuresis was affected by sodium regimen in proportion to the size difference between strains. Neither strain nor dietary sodium had a significant effect on plasma creatinine concentration, urinary creatinine excretion, or total protein excretion.
Plasma AGT and Renin
Total plasma AGT (t-AGT) remained stable through the high to low sodium transition (Figure 1A). PRC increased 2-fold in response to sodium restriction (Figure 1B, P<0.0001), with no significant strain difference.
|
Urinary AGT, Renin, and Aldosterone
In marked contrast with plasma, urinary excretion of t-AGT was significantly increased under high sodium when compared with low sodium (Figure 1C, P<0.0001). The difference among strains was also highly significant (P<0.0001), with a 2-fold higher excretion rate in C57BL/6 than in CD1 animals under either condition of sodium intake. The differences were significant with or without correction for body weight or creatinine excretion. Because we cannot guarantee complete recovery of 24-hour urine, we present the results obtained after adjustment for creatinine excretion. Urinary excretion of u-AGT, as measured by an indirect radioimmunoassay of Ang I released after incubation with excess renin, represented <6% of t-AGT excretion and was only marginally dependent on sodium intake and strain (Figure 1D).
By contrast with PRC, urinary excretion of active renin was higher under high than under low sodium intake (Figure 1E, P<0.0001), with no significant strain difference. Urinary aldosterone excretion measured in a subset of animals was below detection limits under high sodium, but exceeded detection threshold by 2 orders of magnitude under low sodium (Figure 1F).
Expression of PT AGT and CNT Renin
When animals were transferred from high to low dietary sodium, no significant difference in AGT expression could be detected by either semiquantitative immunohistochemistry of the protein (Figure 2A through 2D) or quantitation of mRNA (Figure 2E). CNT renin, evaluated only by semiquantitative histology, did not exhibit significant variation with dietary sodium (Figure 2F through 2I).
|
| Discussion |
|---|
|
|
|---|
Plasma t-AGT concentration was not affected by either dietary sodium or genetic background. The size of circulating AGT (61 to 65 kDa) precludes glomerular filtration under normal physiological conditions.23 Although degradation fragments of AGT could escape this exclusion, a direct examination of immunoreactive AGT in plasma after electrophoresis and Western blotting confirms that smaller cross-reacting species constitute at best a very minor fraction of total circulating AGT (Rohrwasser, unpublished observations). It follows that urinary AGT is of PT origin. Urinary excretion of t-AGT was consistently higher in C57BL/6 than in CD1 under both conditions of sodium intake. This difference was observed whether t-AGT was expressed relative to body weight or relative to creatinine excretion. Several elements indicate that increased glomerular leakage of systemic AGT induced by increased dietary sodium is unlikely to account for this observation: (1) the modest rise in mean arterial pressure (10 to 15 mm Hg) induced by short-term (10 to 15 days) increase in dietary sodium is not likely to induce significant glomerular damage; (2) the difference observed between strains is present under either high or low sodium intake; and (3) urinary protein excretion (Table) is not significantly affected by either sodium regimen or strain. This observation may reflect a genetic difference in renal sodium handling between the 2 species. Uncleaved AGT, as measured by an indirect radioimmunoassay, accounted for
6% of t-AGT, suggesting that most of the renin substrate released in luminal fluid may be consumed in the nephron or in the lower urinary tract. We cannot exclude, however, the possibility that some hydrolysis occurred during timed collection of voided urine, as measurement of urinary renin precluded aspartyl proteinase inhibition.
Although PRC was inversely related to dietary sodium, urinary excretion of active renin paralleled dietary sodium. The origin of urinary renin remains unclear. Micropuncture studies of rat PTs have provided direct evidence that this small protein (36 to 40 kDa) can be found in glomerular ultrafiltrate at a fifth of its plasma concentration and that it is rapidly reabsorbed along the PT.7 The escape of even a small fraction from such fate could contribute substantially to renin in final urine, however. Although renin may also be synthesized in PTs,8 this contribution is likely to be small at best, as it is not detected by immunohistochemistry of renal tissue. We have reported renin synthesis and secretion by principal cells of connecting tubule or by CNT cells.1 Evidence that renin may be added to the urine in a distal segment of the nephron was provided by stop-flow studies in dog.24 De novo renin synthesis in distal nephron segments has also been reported in rats subjected to subtotal nephrectomy.25
The decrease in urinary AGT excretion observed under low sodium appeared at odds with the previous observation that AGT mRNA in PT was increased by a combination of dietary sodium restriction and furosemide treatment.4 No quantitative difference could be noted in AGT mRNA under the present experimental conditions (Figure 2). In an ancillary experiment, animals were subjected to 24-hour water deprivation. A significant increase in immunoreactive AGT was observed in proximal tubules after water deprivation (Figure 3A through 3C, P=0.003). Using expression analysis, we observed a similar trend that did not reach statistical significance (Figure 3D). We speculate that the lack of statistical significance might be the result of our small sample size (n=3). These data suggest that sodium restriction and volume depletion exert different effects on AGT expression in PTs. In conditions in which only dietary sodium is manipulated, changes in urinary excretion of AGT that do not correlate with variation in synthesis may reflect the dependence of reabsorption of the protein in PT on net tubular flow in this nephron segment. Our previous observation of an acute increase in urinary u-AGT concentration when animals are switched to a low sodium diet may have resulted from dehydration concurrent with the 24-hour food deprivation that preceded this dietary change.1
|
Urinary renin excretion has been examined under conditions of either dietary sodium restriction or sodium and volume depletion induced by loop diuretics. The observation that urinary renin parallels26,27 or is dissociated from a rise in plasma renin28 may depend on the relative contributions, in the experimental maneuver applied, of sodium restriction on one hand and sodium or volume depletion on the other. In our experiments, manipulations of dietary sodium in solid food while maintaining free access to water led only to moderate increases in PRC that did not impact on urinary excretion. Volume depletion, by contrast, may lead to enhanced urinary renin through either one or both of 2 mechanisms: (1) the marked rise in systemic renin, leading to increased renin in the ultrafiltrate, may saturate the reabsorbing capacity of PT24,29; and (2) activation of CNT renin may also contribute to enhanced urinary renin excretion. In dehydrated animals, we have observed significant elevation of CNT renin (Figure 3E through 3G, P=0.02). As in the case of AGT, decreased tubular flow under conditions of dietary sodium restriction may lead to increased fractional reabsorption of filtered renin. The modest rise in systemic renin induced by euvolemic sodium restriction may not have been sufficient to compensate for or to saturate this transport.
In conclusion, urinary excretion of AGT and renin reflect the interplay of systemic and tubular changes that affect both secretion and reabsorption of the proteins. Although sodium restriction and volume depletion exert different effects on synthesis of the 2 proteins, excretion in final urine may predominantly reflect changes in net tubular flow. Recent work and literature reviewed therein30 supports the significance of sodium reabsorption in PTs as an independent determinant of blood pressure response to sodium in human hypertension. Our observations on AGT excretion as a function of dietary sodium suggests that this parameter may correlate with net sodium and water reabsorption in this segment and may serve as indicator of PT function.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received September 5, 2001; first decision October 29, 2001; accepted March 12, 2002.
| References |
|---|
|
|
|---|
2. Richoux JP, Cordonnier JL, Bouhnik J, Clauser E, Corvol P, Menard J, Grignon G. Immunocytochemical localization of angiotensinogen in rat liver and kidney. Cell Tissue Res. 1983; 233: 439451.[CrossRef][Medline] [Order article via Infotrieve]
3. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest. 1986; 78: 3139.[Medline] [Order article via Infotrieve]
4. Ingelfinger JR, Pratt RE, Ellison K, Dzau VJ. Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. J Clin Invest. 1986; 78: 13111315.[Medline] [Order article via Infotrieve]
5. Yoshiya M, Tsutsui Y, Itoh N, Okamoto H. Angiotensinogen excretion in rat urine: effects of lipopolysaccharide treatment and sodium balance. Jpn J Pharmacol. 1991; 57: 3744.[Medline] [Order article via Infotrieve]
6. Navar LG, Lewis L, Hymel A, Mitchell KD. Proximal tubular fluid levels of angiotensinogen in anesthetized rats. FASEB J. 1996; 10: A22.Abstract.
7. Leyssac PP. A Micropuncture study of glomerular filtration and tubular reabsorption of endogenous renin in the rat. Renal Physiol Basel. 1978; 1: 181188.
8. Moe OW, Ujiie K, Star RA, Miller RT, Widell J, Alpern RJ, Henrich WL. Renin expression in renal proximal tubule. J Clin Invest. 1993; 91: 774779.[Medline] [Order article via Infotrieve]
9. Chen M, Harris MP, Rose D, Smart A, He XR, Kretzler M, Briggs JP, Schnermann J. Renin and renin mRNA in proximal tubules of the rat kidney. J Clin Invest. 1994; 94: 237243.[Medline] [Order article via Infotrieve]
10. Casarini DE, Boim MA, Stella RC, Krieger-Azzolini MH, Krieger JE, Schor N. Angiotensin Iconverting enzyme activity in tubular fluid along the rat nephron. Am J Physiol. 1997; 272: F405F409.[Medline] [Order article via Infotrieve]
11. Harrison-Bernard LM, Navar LG, Ho MM, Vinson GP, el-Dahr SS. Immunohistochemical localization of ANG II AT1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol. 1997; 273: F170F177.[Medline] [Order article via Infotrieve]
12. Seikaly MG, Arant BSJ, Seney FDJ. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest. 1990; 86: 13521357.[Medline] [Order article via Infotrieve]
13. Navar LG, Lewis L, Hymel A, Braam B, Mitchell KD. Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats. J Am Soc Nephrol. 1994; 5: 11531158.[Abstract]
14. Liu FY, Cogan MG. Angiotensin II stimulation of hydrogen ion secretion in the rat early proximal tubule: modes of action, mechanism, and kinetics. J Clin Invest. 1988; 82: 601607.[Medline] [Order article via Infotrieve]
15. Wang T, Giebisch G. Effects of angiotensin II on electrolyte transport in the early and late distal tubule in rat kidney. Am J Physiol. 1996; 271: F143F149.[Medline] [Order article via Infotrieve]
16.
Davisson RL, Ding Y, Stec DE, Catterall JF, Sigmund CD. Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. Physiol Genomics. 1999; 1: 39.
17.
Meneton P, Ichikawa I, Inagami T, Schnermann J. Renal physiology of the mouse. Am J Physiol Renal Physiol. 2000; 278: F339F351.
18. Carlson SH, Wyss JM. Long-term telemetric recording of arterial pressure and heart rate in mice fed basal and high NaCl diets. Hypertension. 2000; 35: e1e5.[Medline] [Order article via Infotrieve]
19. Sugiyama F, Churchill GA, Higgins DC, Johns C, Makaritsis KP, Gavras H, Paigen B. Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. Genomics. 2001; 71: 707.[CrossRef][Medline] [Order article via Infotrieve]
20. Misono KS, Holladay LA, Murakami K, Kuromizu K, Inagami T. Rapid and large-scale purification and characterization of renin from mouse submaxillary gland. Arch Biochem Biophys. 1982; 217: 574581.[CrossRef][Medline] [Order article via Infotrieve]
21. Crispens CG. Handbook on the Laboratory /mouse. Spingfield, Ill: C.C. Thomas; 1975.
22.
Hefler LA, Tempfer CB, Moreno RM, OBrien WE, Gregg AR. Endothelial-derived nitric oxide and angiotensinogen: blood pressure and metabolism during mouse pregnancy. Am J Physiol Regul Integr Comp Physiol. 2001; 280: R174R182.
23. Tewksbury D , Angiotensinogen.In: Fray JCS, ed. The Endocrine System: Endocrine Regulation of Water and Electrolyte Balance: Handbook of Physiology, Section 7. Oxford: Oxford University Press; 2000.
24.
Bailie MD, Donoso VS, Porter TM. Urinary excretion of renin in the dog: effect of changes in plasma renin. J Pharmacol Exp Ther. 1983; 225: 366371.
25.
Gilbert RE, Wu LL, Kelly DJ, Cox A, Wilkinson-Berka JL, Johnston CI, Cooper ME. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy: implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol. 1999; 155: 429440.
26.
Lumbers ER, Skinner SL. Observations on the origin of renin in human urine. Circ Res. 1969; 24: 689697.
27. Hayduk K, Boucher R, Genest J. Renin activity in urine, plasma, and renal cortex of dogs during changes in sodium balance. Proc Soc Exp Biol Med. 1971; 136: 399402.[CrossRef][Medline] [Order article via Infotrieve]
28. Haley WE, Johnson JW. Measurement of urinary renin activity by radioimmunoassay: sequential studies in acute renal failure in man. Nephron. 1978; 20: 273285.[Medline] [Order article via Infotrieve]
29. Poulsen K, Nielsen AH, Johannessen A. Measurement of inactive renin in normal, nephrectomized, and adrenalectomized rats. Can J Physiol Pharmacol. 1991; 69: 13811384.[Medline] [Order article via Infotrieve]
30.
Chiolero A, Maillard M, Nussberger J, Brunner HR, Burnier M. Proximal sodium reabsorption: an independent determinant of blood pressure response to salt. Hypertension. 2000; 36: 631637.
This article has been cited by other articles:
![]() |
H. Kobori, A. B. Alper Jr, R. Shenava, A. Katsurada, T. Saito, N. Ohashi, M. Urushihara, K. Miyata, R. Satou, L. L. Hamm, et al. Urinary Angiotensinogen as a Novel Biomarker of the Intrarenal Renin-Angiotensin System Status in Hypertensive Patients Hypertension, February 1, 2009; 53(2): 344 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Prieto-Carrasquero, F. T. Botros, J. Pagan, H. Kobori, D. M. Seth, D. E. Casarini, and L. G. Navar Collecting Duct Renin Is Upregulated in Both Kidneys of 2-Kidney, 1-Clip Goldblatt Hypertensive Rats Hypertension, June 1, 2008; 51(6): 1590 - 1596. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kobori, A. Katsurada, K. Miyata, N. Ohashi, R. Satou, T. Saito, Y. Hagiwara, K. Miyashita, and L. G. Navar Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1257 - F1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-B. Linhart and J. A. Majzoub Pomc Knockout Mice Have Secondary Hyperaldosteronism Despite an Absence of Adrenocorticotropin Endocrinology, February 1, 2008; 149(2): 681 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Lalouel and A. Rohrwasser Genetic Susceptibility to Essential Hypertension: Insight From Angiotensinogen Hypertension, March 1, 2007; 49(3): 597 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Picard, M. Van Abel, C. Campone, M. Seiler, M. Bloch-Faure, J. G.J. Hoenderop, J. Loffing, P. Meneton, R. J.M. Bindels, M. Paillard, et al. Tissue Kallikrein-Deficient Mice Display a Defect in Renal Tubular Calcium Absorption J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3602 - 3610. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Prieto-Carrasquero, H. Kobori, Y. Ozawa, A. Gutierrez, D. Seth, and L. G. Navar AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats Am J Physiol Renal Physiol, September 1, 2005; 289(3): F632 - F637. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Meneton, J. Loffing, and D. G. Warnock Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule Am J Physiol Renal Physiol, October 1, 2004; 287(4): F593 - F601. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Prieto-Carrasquero, L. M. Harrison-Bernard, H. Kobori, Y. Ozawa, K. S. Hering-Smith, L. L. Hamm, and L. G. Navar Enhancement of Collecting Duct Renin in Angiotensin II-Dependent Hypertensive Rats Hypertension, August 1, 2004; 44(2): 223 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Jones Dietary Sodium and Blood Pressure Hypertension, May 1, 2004; 43(5): 932 - 935. [Full Text] [PDF] |
||||
![]() |
H. Kobori, M. C. Prieto-Carrasquero, Y. Ozawa, and L. G. Navar AT1 Receptor Mediated Augmentation of Intrarenal Angiotensinogen in Angiotensin II-Dependent Hypertension Hypertension, May 1, 2004; 43(5): 1126 - 1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kobori, A. Nishiyama, L. M. Harrison-Bernard, and L. G. Navar Urinary Angiotensinogen as an Indicator of Intrarenal Angiotensin Status in Hypertension Hypertension, January 1, 2003; 41(1): 42 - 49. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |